Teva Pharmaceutical Industries Ltd (TEVA)
18.74
+0.28
(+1.54%)
USD |
NYSE |
Nov 04, 13:00
Teva Pharmaceutical Industries Market Cap: 21.23B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 20.90B |
| October 31, 2024 | 20.89B |
| October 30, 2024 | 21.06B |
| October 29, 2024 | 20.88B |
| October 28, 2024 | 20.81B |
| October 25, 2024 | 20.28B |
| October 24, 2024 | 20.68B |
| October 23, 2024 | 20.86B |
| October 22, 2024 | 20.82B |
| October 21, 2024 | 20.60B |
| October 18, 2024 | 20.34B |
| October 17, 2024 | 20.35B |
| October 16, 2024 | 20.42B |
| October 15, 2024 | 20.56B |
| October 14, 2024 | 19.53B |
| October 11, 2024 | 19.54B |
| October 10, 2024 | 19.72B |
| October 09, 2024 | 20.09B |
| October 08, 2024 | 19.86B |
| October 07, 2024 | 19.58B |
| October 04, 2024 | 19.81B |
| October 03, 2024 | 19.69B |
| October 02, 2024 | 19.78B |
| October 01, 2024 | 20.02B |
| September 30, 2024 | 20.42B |
| Date | Value |
|---|---|
| September 27, 2024 | 19.78B |
| September 26, 2024 | 20.10B |
| September 25, 2024 | 19.78B |
| September 24, 2024 | 20.09B |
| September 23, 2024 | 20.08B |
| September 20, 2024 | 19.84B |
| September 19, 2024 | 20.12B |
| September 18, 2024 | 20.26B |
| September 17, 2024 | 20.22B |
| September 16, 2024 | 20.47B |
| September 13, 2024 | 20.86B |
| September 12, 2024 | 20.40B |
| September 11, 2024 | 20.35B |
| September 10, 2024 | 19.85B |
| September 09, 2024 | 20.17B |
| September 06, 2024 | 20.48B |
| September 05, 2024 | 20.88B |
| September 04, 2024 | 21.48B |
| September 03, 2024 | 20.98B |
| August 30, 2024 | 21.38B |
| August 29, 2024 | 21.22B |
| August 28, 2024 | 21.03B |
| August 27, 2024 | 21.25B |
| August 26, 2024 | 21.07B |
| August 23, 2024 | 21.03B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
7.328B
Minimum
Mar 18 2020
21.48B
Maximum
Sep 04 2024
11.78B
Average
10.88B
Median
Dec 23 2019
Market Cap Benchmarks
| Amicus Therapeutics Inc | 3.414B |
| Compugen Ltd | 149.53M |
| Pluri Inc | 26.26M |
| Can Fite Biofarma Ltd | 13.41M |
| BiomX Inc | 11.81M |
Market Cap Related Metrics
| PS Ratio | 1.297 |
| Price to Book Value | 3.338 |
| Price to Free Cash Flow | 31.11 |
| Price | 18.74 |
| Earnings Yield | -2.08% |
| Operating PE Ratio | 6.098 |
| Normalized PE Ratio | 11.98 |